{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:41:36Z","timestamp":1791225696919,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.4065\/mcp.2010.0800","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T02:57:10Z","timestamp":1305601030000},"page":"480-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Nitrofurantoin Compares Favorably to Recommended Agents as Empirical Treatment of Uncomplicated Urinary Tract Infections in a Decision and Cost Analysis"],"prefix":"10.4065","volume":"86","author":[{"given":"James A.","family":"McKinnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Stollenwerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin W.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren G.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/mcp.2010.0800_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","article-title":"Urinary tract infection: self-reported incidence and associated costs","volume":"10","author":"Foxman","year":"2000","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.4065\/mcp.2010.0800_bib2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0891-5520(20)30149-5","article-title":"Diagnosis and treatment of acute urinary tract infections [published correction appears in Infect Dis Clin North Am. 1990;4(2):following xii]","volume":"1","author":"Johnson","year":"1987","journal-title":"Infect Dis Clin North Am"},{"key":"10.4065\/mcp.2010.0800_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.281.8.736","article-title":"Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women","volume":"281","author":"Gupta","year":"1999","journal-title":"JAMA"},{"issue":"8","key":"10.4065\/mcp.2010.0800_bib4","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1128\/AAC.46.8.2540-2545.2002","article-title":"Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States","volume":"46","author":"Karlowsky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/mcp.2010.0800_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/dkg028","article-title":"An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project","volume":"51","author":"Kahlmeter","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/mcp.2010.0800_bib6","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"suppl A","key":"10.4065\/mcp.2010.0800_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/33.suppl_A.121","article-title":"Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice","volume":"33","author":"Spencer","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/mcp.2010.0800_bib8","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/archinte.167.20.2207","article-title":"Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women","volume":"167","author":"Gupta","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.4065\/mcp.2010.0800_bib9","series-title":"2010 Red Book: Pharmacy's Fundamental Reference","year":"2010"},{"key":"10.4065\/mcp.2010.0800_bib10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1086\/322603","article-title":"Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis","volume":"33","author":"Le","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.4065\/mcp.2010.0800_bib11","first-page":"35","article-title":"Escherichia coli resistance in uncomplicated urinary tract infection: a model for determining when to change first-line empirical antibiotic choice","volume":"15","author":"Perfetto","year":"2002","journal-title":"Manag Care Interface"},{"key":"10.4065\/mcp.2010.0800_bib12","first-page":"17","article-title":"Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy","volume":"10","author":"Perfetto","year":"2004","journal-title":"J Manag Care Pharm"},{"key":"10.4065\/mcp.2010.0800_bib13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.4065\/mcp.2010.0800_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0094-0143(05)70214-7","article-title":"Management of lower urinary tract infections and cystitis","volume":"26","author":"Anderson","year":"1999","journal-title":"Urol Clin North Am"},{"key":"10.4065\/mcp.2010.0800_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0924-8579(99)00023-0","article-title":"Practice guidelines for urinary tract infection in the era of managed care","volume":"11","author":"Hooton","year":"1999","journal-title":"Int J Antimicrob Agents"},{"issue":"suppl 1","key":"10.4065\/mcp.2010.0800_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/46.suppl_1.1","article-title":"Pathogenesis of urinary tract infections: an update","volume":"46","author":"Hooton","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/mcp.2010.0800_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-102-2-244","article-title":"Management of acute dysuria: a decision-analysis model of alternative strategies","volume":"102","author":"Carlson","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.4065\/mcp.2010.0800_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0090-4295(91)80312-U","article-title":"Advances in the understanding and treatment of urinary tract infections in young women","volume":"37","author":"Iravani","year":"1991","journal-title":"Urology"},{"key":"10.4065\/mcp.2010.0800_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/520138","article-title":"Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis","volume":"29","author":"Echols","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.4065\/mcp.2010.0800_bib20","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-111-11-906","article-title":"Urinary tract infections in women: diagnosis and treatment","volume":"111","author":"Johnson","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.4065\/mcp.2010.0800_bib21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for the antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.4065\/mcp.2010.0800_bib22","first-page":"49","article-title":"Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies","volume":"44","author":"Barry","year":"1997","journal-title":"J Fam Pract"},{"issue":"11","key":"10.4065\/mcp.2010.0800_bib23","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0149-2918(00)86734-X","article-title":"Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection","volume":"21","author":"Stein","year":"1999","journal-title":"Clin Ther"},{"issue":"suppl A","key":"10.4065\/mcp.2010.0800_bib24","first-page":"67","article-title":"A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection","volume":"43","author":"Iravani","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/mcp.2010.0800_bib25","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0149-2918(02)80099-6","article-title":"Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women","volume":"24","author":"Henry","year":"2002","journal-title":"Clin Ther"},{"key":"10.4065\/mcp.2010.0800_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1086\/322603","article-title":"Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis","volume":"33","author":"Le","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.4065\/mcp.2010.0800_bib27","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ijantimicag.2003.12.005","article-title":"Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections","volume":"23S1","author":"Talan","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.4065\/mcp.2010.0800_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archinte.166.6.635","article-title":"Current antibiotic therapy for isolated urinary tract infections in women","volume":"166","author":"Kallen","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.4065\/mcp.2010.0800_bib29","series-title":"2007 Red Book: Pharmacy's Fundamental Reference","year":"2007"},{"key":"10.4065\/mcp.2010.0800_bib30","series-title":"AHA Hospital Statistics","year":"2007"},{"key":"10.4065\/mcp.2010.0800_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.1995.03520250057034","article-title":"Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women","volume":"273","author":"Hooton","year":"1995","journal-title":"JAMA"},{"key":"10.4065\/mcp.2010.0800_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7326\/0003-4819-139-2-200307150-00011","article-title":"Diagnosis and management of adults with pharyngitis: a cost-effectiveness analysis","volume":"139","author":"Neuner","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.4065\/mcp.2010.0800_bib33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0895-4356(96)00218-1","article-title":"The cost-effectiveness of placing urinary tract infection treatment over the counter","volume":"49","author":"Rubin","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.4065\/mcp.2010.0800_bib34","author":"Centers for Medicare and Medicaid Services"},{"issue":"5","key":"10.4065\/mcp.2010.0800_bib35","first-page":"548","article-title":"Treatment of serious urinary tract infections at a university teaching hospital: a retrospective chart review","volume":"25","author":"Coley","year":"1990","journal-title":"Hosp Formul"},{"issue":"930","key":"10.4065\/mcp.2010.0800_bib36","first-page":"102","article-title":"Comparison of ciprofloxacin and netilmicin for the treatment of acute pyelonephritis","volume":"105","author":"Bailey","year":"1992","journal-title":"N Z Med J"},{"issue":"12","key":"10.4065\/mcp.2010.0800_bib37","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.4065\/mcp.2010.0800_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s101560170023","article-title":"Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis","volume":"7","author":"Takahashi","year":"2001","journal-title":"J Infect Chemother"},{"key":"10.4065\/mcp.2010.0800_bib39","series-title":"AHA Hospital Statistics","year":"2010"},{"issue":"8","key":"10.4065\/mcp.2010.0800_bib40","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/339491","article-title":"Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan","volume":"34","author":"Brown","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.4065\/mcp.2010.0800_bib41","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/339812","article-title":"Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens","volume":"34","author":"Raz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.4065\/mcp.2010.0800_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0094-0143(05)70057-4","article-title":"Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women","volume":"25","author":"Engel","year":"1998","journal-title":"Urol Clin North Am"},{"key":"10.4065\/mcp.2010.0800_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0924-8579(99)00024-2","article-title":"Pharmacoeconomics of treating uncomplicated urinary tract infections","volume":"11","author":"Rosenberg","year":"1999","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.4065\/mcp.2010.0800_bib44","first-page":"49","article-title":"Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies","volume":"44","author":"Barry","year":"1997","journal-title":"J Fam Pract"},{"issue":"suppl D","key":"10.4065\/mcp.2010.0800_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/18.Supplement_D.103","article-title":"Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women","volume":"18","author":"Henry","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.4065\/mcp.2010.0800_bib46","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0149-2918(99)80018-6","article-title":"Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women","volume":"21","author":"Henry","year":"1999","journal-title":"Clin Ther"},{"issue":"482","key":"10.4065\/mcp.2010.0800_bib47","first-page":"729","article-title":"Randomized controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br J Gen Pract"},{"key":"10.4065\/mcp.2010.0800_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0002-9343(99)00026-1","article-title":"A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim\/sulfamethoxazole for the treatment of acute urinary tract infection in women","volume":"106","author":"McCarty","year":"1999","journal-title":"Am J Med"},{"key":"10.4065\/mcp.2010.0800_bib49","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa033114","article-title":"Maintenance fluconazole therapy for recurrent vulvovaginal candidasis","volume":"351","author":"Sobel","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"10.4065\/mcp.2010.0800_bib50","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.4065\/79.8.1048","article-title":"Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance","volume":"79","author":"Miller","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.4065\/mcp.2010.0800_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1473-3099(05)70086-4","article-title":"Lack of development of new antimicrobial drugs: a potential serious threat to public health","volume":"5","author":"Norrby","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.4065\/mcp.2010.0800_bib52","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1128\/AAC.45.11.3084-3091.2001","article-title":"Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures","volume":"45","author":"McDonald","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/mcp.2010.0800_bib53","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/jac\/47.4.502","article-title":"Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections [letter]","volume":"47","author":"Cizman","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/mcp.2010.0800_bib54","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijantimicag.2006.02.009","article-title":"Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)","volume":"27","author":"Zhanel","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.4065\/mcp.2010.0800_bib55","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jac\/dki344","article-title":"Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey","volume":"56","author":"Arslan","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.4065\/mcp.2010.0800_bib56","first-page":"457","article-title":"Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in the Gaza Strip","volume":"46","author":"Astal","year":"2005","journal-title":"Singapore Med J"},{"key":"10.4065\/mcp.2010.0800_bib57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.amjmed.2008.04.039","article-title":"Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates","volume":"121","author":"Johnson","year":"2008","journal-title":"Am J Med"},{"key":"10.4065\/mcp.2010.0800_bib58","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/AAC.00123-06","article-title":"Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study","volume":"50","author":"Karlowsky","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/mcp.2010.0800_bib59","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br J Gen Pract"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611600451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611600451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:36:58Z","timestamp":1706002618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611600451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0025619611600451"],"URL":"https:\/\/doi.org\/10.4065\/mcp.2010.0800","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitrofurantoin Compares Favorably to Recommended Agents as Empirical Treatment of Uncomplicated Urinary Tract Infections in a Decision and Cost Analysis","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/mcp.2010.0800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.4065\/mcp.2011.0184","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}